CN1678342A - 眼病症治疗 - Google Patents

眼病症治疗 Download PDF

Info

Publication number
CN1678342A
CN1678342A CNA038208113A CN03820811A CN1678342A CN 1678342 A CN1678342 A CN 1678342A CN A038208113 A CNA038208113 A CN A038208113A CN 03820811 A CN03820811 A CN 03820811A CN 1678342 A CN1678342 A CN 1678342A
Authority
CN
China
Prior art keywords
membrane
molecule
bruch
inactive
diffusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038208113A
Other languages
English (en)
Chinese (zh)
Inventor
D·M·施瓦茨
S·弗雷泽
R·H·格鲁布斯
J·P·加利文
喻长军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALIFORNIA SENATE
California Institute of Technology
Original Assignee
CALIFORNIA SENATE
California Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CALIFORNIA SENATE, California Institute of Technology filed Critical CALIFORNIA SENATE
Publication of CN1678342A publication Critical patent/CN1678342A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
CNA038208113A 2002-07-02 2003-07-01 眼病症治疗 Pending CN1678342A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39350502P 2002-07-02 2002-07-02
US60/393,505 2002-07-02

Publications (1)

Publication Number Publication Date
CN1678342A true CN1678342A (zh) 2005-10-05

Family

ID=30115595

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038208113A Pending CN1678342A (zh) 2002-07-02 2003-07-01 眼病症治疗

Country Status (6)

Country Link
US (2) US7381404B2 (https=)
EP (1) EP1539222A1 (https=)
JP (1) JP2005532393A (https=)
CN (1) CN1678342A (https=)
CA (1) CA2491128A1 (https=)
WO (1) WO2004004757A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656621A (zh) * 2013-12-02 2014-03-26 黄丽娜 一种新型鼠神经生长因子玻璃体腔注射给药系统及其应用
CN103877430A (zh) * 2014-04-20 2014-06-25 赵华 一种治疗黄斑变性的药物及制备方法
WO2015081854A1 (zh) * 2013-12-02 2015-06-11 黄丽娜 一种白蒺藜皂苷玻璃体腔注射给药系统及其应用
CN110494148A (zh) * 2017-02-09 2019-11-22 安特瑞珍有限公司 将人参/红参及海参复合提取物作为有效成分的布鲁赫膜功能下降相关疾病预防或治疗用组合物

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539222A1 (en) * 2002-07-02 2005-06-15 The Regents Of The University Of California Treatment for eye disorder
WO2005110397A1 (en) * 2004-05-07 2005-11-24 The Regents Of The University Of California Treatment of myopia
US7654540B2 (en) * 2004-06-18 2010-02-02 Bose Corporation Electromechanical transducing
US20070213693A1 (en) * 2004-08-27 2007-09-13 Ellex Medical Pty Ltd Selective ophthalmic laser treatment
JP2006195240A (ja) * 2005-01-14 2006-07-27 Fuji Photo Film Co Ltd 断層画像化装置
US7668342B2 (en) 2005-09-09 2010-02-23 Carl Zeiss Meditec, Inc. Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US7768652B2 (en) * 2006-03-16 2010-08-03 Carl Zeiss Meditec, Inc. Methods for mapping tissue with optical coherence tomography data
CN101500640B (zh) * 2006-06-15 2013-10-16 海鸥Ip有限公司 递送系统和方法
DE102006030382A1 (de) * 2006-06-29 2008-01-03 Carl Zeiss Meditec Ag Verfahren und Vorrichtung zur optischen Detektion am Auge
AT504159A1 (de) * 2006-08-16 2008-03-15 Marlyn Nutraceuticals Inc Verwendung von proteasen
US8043235B2 (en) * 2006-08-22 2011-10-25 Schwartz Donald N Ultrasonic treatment of glaucoma
CA2667673C (en) 2006-10-25 2016-08-23 Ellex R&D Pty Ltd Retinal regeneration
ES2666300T3 (es) * 2007-02-15 2018-05-03 The Uab Research Foundation Método de fotoblanqueamiento mejorado
DK2170232T3 (en) * 2007-05-30 2017-09-25 Ellex R&D Pty Ltd Laser for retinal rejuvenation
EP2309919B1 (en) 2008-07-10 2019-03-06 Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO Functional optical coherent imaging
KR101018785B1 (ko) * 2008-11-28 2011-03-03 삼성전기주식회사 전자기 밴드갭 구조물 및 회로 기판
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US9226654B2 (en) 2011-04-29 2016-01-05 Carl Zeiss Meditec, Inc. Systems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
EP2840957B1 (en) 2012-04-27 2024-01-03 Stryker European Operations Limited Optical coherent imaging medical device and method
EP2872035B1 (en) * 2012-07-10 2020-09-30 Aïmago S.A. Perfusion assessment multi-modality optical medical device
CN107735015B (zh) 2015-05-07 2021-09-10 史赛克欧洲运营有限公司 使用彩色图像传感器的用于组织的激光散斑成像的方法和系统
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
US11300452B2 (en) 2017-06-08 2022-04-12 Ushio Denki Kabushiki Kaisha Spectral measurement method, spectral measurement system, and broadband pulsed light source unit
US20180360655A1 (en) * 2017-06-16 2018-12-20 Michael S. Berlin Methods and systems for oct guided glaucoma surgery

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US87985A (en) * 1869-03-16 Improved rotary metal-cotter
US220245A (en) * 1879-10-07 Improvement in provision-safes
US6A (en) * 1836-08-10 Thomas Blanchard Machine for forming end pieces of plank blocks for ships
US138329A (en) * 1873-04-29 Improvement in wheel-plows
US91229A (en) * 1869-06-15 Improvement in feeding-device for machines for combing- cotton
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US20030087985A1 (en) 1990-10-15 2003-05-08 Hubbell Jeffrey A. Gels for encapsulation of biological materials
US5626863A (en) 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
KR100266912B1 (ko) 1992-02-28 2000-12-01 파라비 레이 조직접촉물질이며 방출조절운반체인 광중합성 생분해성 하이드로겔
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5468505A (en) 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US20040138329A1 (en) 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
US5310764A (en) 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
US5800373A (en) 1995-03-23 1998-09-01 Focal, Inc. Initiator priming for improved adherence of gels to substrates
US5458505A (en) * 1994-02-03 1995-10-17 Prager; Jay H. Lamp cooling system
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US5935942A (en) 1994-12-14 1999-08-10 Zeimer; Ran Selective and non-invasive visualization or treatment of vasculature
CA2215309C (en) 1995-03-23 2008-11-25 Focal, Inc. Redox and photoinitiator systems for priming for improved adherence of gels to substrates
US6461640B1 (en) 1995-12-08 2002-10-08 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US6059828A (en) 1996-03-18 2000-05-09 Peyman; Gholam A. Macular indentor for use in the treatment of subretinal neovascular membranes
NZ502358A (en) 1997-07-18 2002-11-26 Infimed Therapeutics Inc Hydrogel composition comprising a biologically active substance combined with a macromer
US6128525A (en) 1997-07-29 2000-10-03 Zeng; Haishan Apparatus and method to monitor photodynamic therapy (PDT)
WO1999021512A1 (en) 1997-10-27 1999-05-06 The Regents Of The University Of California Methods and pharmaceutical compositions for the closure of retinal breaks
US6472541B2 (en) 1998-11-20 2002-10-29 The Regents Of The University Of California Protecting groups with increased photosensitivities
US6858229B1 (en) 1999-04-26 2005-02-22 California Institute Of Technology In situ forming hydrogels
DE19920158A1 (de) * 1999-04-29 2000-11-02 Univ Schiller Jena Verfahren und Anordnung zur Bestimmung von Fluorophoren an Objekten, insbesondere am lebenden Augenhintergrund
US6271233B1 (en) * 1999-08-10 2001-08-07 Ciba Vision Corporation Method for treating ocular neovascular diseases
US6267954B1 (en) 1999-11-24 2001-07-31 Universite De Paris V Rene-Descartes Intraocular transplantation of encapsulated cells
EP1267935A2 (en) 2000-01-12 2003-01-02 Light Sciences Corporation Novel treatment for eye disease
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
US7291673B2 (en) 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
JP2005511713A (ja) 2001-12-07 2005-04-28 ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア 加齢性黄斑変性についての処置
EP1539222A1 (en) 2002-07-02 2005-06-15 The Regents Of The University Of California Treatment for eye disorder
US20040199130A1 (en) * 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656621A (zh) * 2013-12-02 2014-03-26 黄丽娜 一种新型鼠神经生长因子玻璃体腔注射给药系统及其应用
WO2015081854A1 (zh) * 2013-12-02 2015-06-11 黄丽娜 一种白蒺藜皂苷玻璃体腔注射给药系统及其应用
CN103877430A (zh) * 2014-04-20 2014-06-25 赵华 一种治疗黄斑变性的药物及制备方法
CN103877430B (zh) * 2014-04-20 2016-04-20 赵华 一种治疗黄斑变性的药物及制备方法
CN110494148A (zh) * 2017-02-09 2019-11-22 安特瑞珍有限公司 将人参/红参及海参复合提取物作为有效成分的布鲁赫膜功能下降相关疾病预防或治疗用组合物
CN110494148B (zh) * 2017-02-09 2023-10-27 安特瑞珍有限公司 人参/红参及海参复合提取物作为有效成分的布鲁赫膜功能下降相关疾病预防或治疗用组合物

Also Published As

Publication number Publication date
US8298521B2 (en) 2012-10-30
US20080286255A1 (en) 2008-11-20
EP1539222A1 (en) 2005-06-15
CA2491128A1 (en) 2004-01-15
WO2004004757A8 (en) 2004-10-07
US20050048044A1 (en) 2005-03-03
JP2005532393A (ja) 2005-10-27
WO2004004757A1 (en) 2004-01-15
US7381404B2 (en) 2008-06-03

Similar Documents

Publication Publication Date Title
CN1678342A (zh) 眼病症治疗
CN1104908C (zh) 通过对眼的光动力学治疗改善视力
Miller et al. Photodynamic therapy of subretinal neovascularization in the monkey eye
CN1582156A (zh) 眼新血管疾病的治疗方法
US6942655B2 (en) Method to treat age-related macular degeneration
CN105056206A (zh) 用于预防或治疗眼科病症的方法和组合物
JP2005532393A5 (https=)
CN1604775A (zh) 通过gaba药物调节眼生长和近视
EP1262179A1 (en) Photodynamic therapy for selectively closing neovasa in eyeground tissue
CN1246054A (zh) 绿卟啉用于生产治疗继发性白内障的药物的用途
Kunchithapautham et al. Differential effects of rapamycin on rods and cones during light-induced stress in albino mice
Rechtman et al. An update on photodynamic therapy in age-related macular degeneration
CN1269729A (zh) 减轻炎症作用的组合物和制品
Spaide Central serous chorioretinopathy
Moshfeghi et al. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies
CN121666218A (zh) 提高玻璃体与视网膜之间的粘附
US9040079B2 (en) Pegylated compounds for age-related macular degeneration
AU2003253767A1 (en) Treatment for eye disorder
KR20050021375A (ko) 안질환의 치료 방법
RU2682496C1 (ru) Способ лазерного лечения хронической рецидивирующей центральной серозной хориоретинопатии
EP4186524A1 (en) Prevention and/or treatment of eye disease by collagen fiber crosslinking
CN100534428C (zh) 血卟啉单甲醚在治疗眼科疾病中的应用
RU2333022C1 (ru) Способ фотодинамической терапии хориоидальных неоваскулярных мембран
RU2161940C2 (ru) Способ лечения помутнений роговицы после вирусных кератитов
HK1069999A (en) Methods for treating ocular neovascular diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication